Claritas Rx
South San Francisco, US · Founded 2021 · Delaware corporation · 136 employees on LinkedIn · 1 known investors
Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
Founders & leadership
SK
Stuart KaminSVP, Analytics & Innovation
MF
Mike FitzgibbonsCEO
BB
Bhupesh BajajChief Technology Officer
MV
Manoshi VasudevanNamed on SEC filing
NK
Nicholas KrokoszynskiNamed on SEC filing
MB
Mauricio BuitragoNamed on SEC filing
Board
BS
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.1M disclosed across 4 rounds · 2017–2021
▶$13.6MraisedFeb 2021 · 9 investors · Other TechnologyRule 506(b)
▶$13.6MraisedFeb 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Manoshi VasudevanExecutive Officer
- Nicholas KrokoszynskiExecutive Officer
- Bradley SloanDirector
- Stuart KaminExecutive Officer
- Mauricio BuitragoExecutive Officer
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- Minimum investment
- $25K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$997KraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$997KraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $997K
- Amount sold
- $997K
- Minimum investment
- $50K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJul 2020 · 20 investors · Other TechnologyRule 506(b)
▶$2.9MraisedJul 2020 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $25K
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- Jan 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA53 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Syneos Health50 shared keywordsSyneos Health is a contract research and commercialization services company that supports biopharmaceutical companies in drug development, regulatory affairs, and market launch across therapeutic areas. The firm employs over 26,000 specialists including MDs and PhDs to help clients develop and commercialize pharmaceuticals globally.
ConnectiveRx48 shared keywordsConnectiveRx provides hub services, patient support, and patient affordability programs that help pharmaceutical manufacturers, healthcare providers, and patients access and stay on prescribed therapies. It offers point-of-care awareness and adherence messaging as a single-partner solution for medication access in the pharmaceutical industry.
Companies competing with Claritas Rx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Claritas Rx do?
- Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
- Who are Claritas Rx's investors?
- Claritas Rx's investors include Questa Capital.
- How much funding has Claritas Rx raised?
- Claritas Rx has disclosed $19.1M raised across 4 rounds.
- Where is Claritas Rx headquartered?
- Claritas Rx is headquartered in South San Francisco, US.